Carly Simon Discloses Parkinson’s Disease Diagnosis
Legendary singer Carly Simon reveals her Parkinson's disease diagnosis. Discover the impact on her career and personal life.
POLICY WIRE — London, UK — Renowned singer-songwriter Carly Simon has disclosed that she has been diagnosed with Parkinson’s disease. Simon, known for her iconic hits including “You’re So Vain” and “Nobody Does It Better,” shared the news in a recent statement.
“After a series of tests and consultations with medical professionals, I have been diagnosed with Parkinson’s disease,” Simon said. “It’s a challenging diagnosis, but I am determined to face it with the same resilience I’ve shown throughout my career.”
Parkinson’s disease is a progressive disorder of the nervous system that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement.
Simon’s career spans several decades, during which she has won multiple Grammy Awards and sold millions of records worldwide. Her announcement has sparked an outpouring of support from fans — and fellow musicians.
In recent years, Simon has been active in various charitable causes, including those focused on mental health and women’s rights. Despite her diagnosis, she remains committed to these causes and continues to advocate for awareness and support for those affected by chronic illnesses.
“I want to thank my family, friends, — and fans for their unwavering support,” Simon continued. “Your encouragement means the world to me as I navigate this new chapter.”
The music industry has rallied around Simon, with many artists expressing their admiration — and support. “Carly Simon is a true icon, and her strength in facing this challenge is inspiring,” said fellow singer-songwriter Carole King.
Simon’s diagnosis underscores the importance of early detection — and management of Parkinson’s disease. Medical experts emphasize the value of ongoing research — and support for those living with the condition.
Reporting by Policy-Wire (PW)


